Treatment Equipment Company to launch Desalitech’s ReFlex reverse osmosis product line

Desalitech has entered an agreement with Washington’s Treatment Equipment Company (TEC) to provide sales support for municipal water treatment projects in Washington, Idaho, Alaska, Oregon in the US.

The deal covers the launch of Desalitech’s ReFlex reverse osmosis (RO) product line in the regional markets.

The ReFlex systems comes with Desalitech’s patented CCD technology, which is a reverse osmosis process claimed to make maximum water recovery whilst reducing energy consumption.

Treatment Equipment Company president Dennis Gleason was quoted by Water Online as saying: "Desalitech’s product line makes traditionally designed reverse osmosis and nanofiltration systems obsolete.

"Treatment Equipment Company is proud to partner with Desalitech to bring next-generation water treatment to municipalities in our area."

Due to the efficiency of ReFlex systems, investment returns are generated in less than 18 months with high recovery rates that not only save water but also reduce operating costs, Desalitech claimed.

The company has provided ReFlex systems to its Fortune 500 customers worldwide, including Southern California Edison, Coca-Cola and Novelis.

Desalitech CEO Nadav Efraty was quoted by Water Online as saying: "We are thrilled to partner with Treatment Equipment Company to expand the impact of our work in the municipal sector.

"This is yet another promising new partnership that builds on a tremendously exciting winter of activity for Desalitech."

Last month, Desalitech had signed a contract with Novelis as well as entered into a partnership with provider of filtration, separation and purification technologies, Pall Corporation.

As a part of the contract with Novelis, Desalitech had to deliver ultrapure water treatment system for a manufacturing facility in Changzhou, China, while the partnership with Pall will see the two companies provide integrated microfiltration (MF), ultrafiltration (UF) and RO solutions for water treatment applications across the globe.